Current role
Biotechnology · Healthcare
Chief Accounting Officer, CFO
2026-10-19–present
Andrew J. Silver
Chief Accounting Officer
CRISPR Therapeutics AG (CRSP)Equibles does not estimate personal net worth.
About Andrew J. Silver
Andrew J. Silver is recorded as Chief Accounting Officer and CFO at CRISPR Therapeutics AG (CRSP) since October 19, 2026. CRISPR Therapeutics AG reported in an 8-K filed October 19, 2026 that Andrew J. Silver was appointed principal accounting officer, effective October 19, 2026. CRISPR Therapeutics AG reported in an 8-K filed October 19, 2026 that Andrew J. Silver was appointed Chief Financial Officer, effective October 19, 2026. CRISPR Therapeutics AG is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CRISPR Therapeutics AG includes Samarth Kulkarni (CEO), Samarth Kulkarni, Ph.D. (Chairman), Raju Prasad (CFO) and 7 others.
“Mr. Silver will also serve as the Company’s principal financial officer and principal accounting officer.”
“On October 19, 2026, CRISPR Therapeutics AG (the “Company”) announced the promotion of Andrew J. Silver, currently the Company’s SVP, Finance, to be the Company’s Chief Financial Officer effective immediately.”
Affiliation history
-
Current
2026-10-19–present
-
Current
2026-10-19–present
Company network
Leadership on record at CRISPR Therapeutics AG
- Samarth Kulkarni CEO
- Samarth Kulkarni, Ph.D. Chairman
- Raju Prasad CFO
- Raju Prasad, Ph.D. CFO, Chief Accounting Officer
- Julianne Bruno COO
- James R. Kasinger General Counsel
- Ali Behbahani Board Member
- Briggs W. Morrison Board Member
- Christian Rommel Board Member
- Christian Rommel, Ph.D. Board Member